ZyVersa Therapeutics’ CEO, Stephen C. Glover, to Attend JPM’s Healthcare Conference 2025 in San Francisco
18 déc. 2024 07h55 HE
|
ZyVersa Therapeutics
ZyVersa looks forward to meeting with investors and potential collaborators at JPM 2025 to discuss our technology, pipeline, and development milestones.
Tevogen Bio to Attend the 43rd Annual J.P. Morgan Healthcare Conference
10 déc. 2024 15h13 HE
|
Tevogen Bio Inc
WARREN, N.J., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf,...
HEI Civil Announces Appointment of JP Morgan to Chief Operating Officer
12 nov. 2024 12h00 HE
|
HEI Civil
CASTLE ROCK, Colo., Nov. 12, 2024 (GLOBE NEWSWIRE) -- HEI Civil, a national heavy civil construction company, is pleased to announce the promotion of JP Morgan to Chief Operating Officer. Morgan...
Recursion to Participate in Upcoming Investor Conferences
03 juin 2024 09h00 HE
|
Recursion Pharmaceuticals
SALT LAKE CITY, June 03, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its...
Recursion to Participate in Upcoming Investor Conferences
01 mai 2024 08h01 HE
|
Recursion Pharmaceuticals
SALT LAKE CITY, May 01, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its...
CSX Chief Executive Officer to Address JP Morgan Industrials Conference
06 mars 2024 10h00 HE
|
CSX Corporation
JACKSONVILLE, Fla., March 06, 2024 (GLOBE NEWSWIRE) -- CSX Corp. (NASDAQ: CSX) President and Chief Executive Officer, Joe Hinrichs, will address the 2024 JP Morgan Industrials Conference in New York...
Pacific General Appoints Pieter Wernink and John Romney as Senior Advisors
25 janv. 2024 08h57 HE
|
Pacific General
Pacific General, announces the appointment of Pieter Wernick and John Romney as Senior Advisors to Pacific General’s Private Equity team.
Recursion Unveils LOWE Drug Discovery Software at the J.P. Morgan Healthcare Conference
08 janv. 2024 10h59 HE
|
Recursion Pharmaceuticals
SAN FRANCISCO, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today presented a demonstration...
Citeline to Share Exclusive Insights from 42nd Annual J.P. Morgan Healthcare Conference
08 janv. 2024 09h00 HE
|
Citeline
Citeline, a Norstella company, will provide exclusive access, including daily insights, to the 42nd Annual J.P. Morgan Healthcare Conference Jan. 8-11.
AVITA Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
04 janv. 2024 09h00 HE
|
AVITA Medical
AVITA Medical to present at JP Morgan's Annual Healthcare Conference in San Francisco on Thursday, January 11, 2024.